Home >Current Issue
Volume: 9, Issue: 2, February, 2019
Scientific research presentations in pharmacoeconomics and health outcomes research: status of India compared to SAARC and BRICS countriesAuthor Affiliations
South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa (BRICS) countries’ contribution in the field of science and engineering has grown immensely over the decade. BRICS countries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts in research and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomes research field give an indication about healthcare coverage and access decisions. India being significantly major player among SAARC and BRICS countries in terms of economy and policy making, the present study attempted to analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area of pharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and Outcomes Research Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in the study. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICS countries over the last 10 years. The collaborative research with foreign/international authors is also increasing, which is an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said area should be strengthened further which may be beneficial to the society in the coming years.
Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ahmad A, Patel I, Parimilakrishnan S, Mohanta GP, Chung HC, Chang J, The role of Pharmacoeconomics in current Indian healthcare system. J Res Pharm Pract, 2013; 2: 3–9. https://doi.org/10.4103/2279-042X.114081
Ahmad A, Ashraf, Abbas Z. Current Status of Research and Development in the SAARC Region. Sci. Technol. Dev., 2016, 35 (2): 63-66. https://doi.org/10.3923/std.2016.63.66
BRICS.(cited on 14th June 2018). Available at: https://en.wikipedia.org/wiki/BRICS.
BRICS to strengthen cooperation on science and innovation.(cited on 14th July2018).
Available at: http://chinaplus.cri.cn/news/politics/11/20170718/10029.html.
Koçkaya G., Yenilmez FB., Tuna E. Trend of pharmacoeconomics and health outcome studies in Turkey. Proceedings of ISPOR 19th Annual European Congress; 2016 Oct. Vienna, Austria. Abstract nr PHP 243. https://doi.org/10.1016/j.jval.2016.09.784
Lyles A, Recent trends in pharmacoeconomics: Needs and unmet needs. European journal of pharmaceutical sciences. 2008; 34: 7–24. https://doi.org/10.1016/j.ejps.2008.02.028
Muragundi P M.Pharmacoeconomics – fourth dimension for drug evaluation in India.Current Science. 2014; 106:1051.
Hasan SA, Luthra R, Comparative performance of India with other BRICS countries in publishing science and engineering research papers.Current Science.2014; 106:1654-1657.
The role of BRICS in the developing world.(cited on 14th June 2018). Available at:https://www.ab.gov.tr/files/ardb/evt/1_avrupa_birligi/1_9_politikalar/1_9_8_dis_politika/The_role_of_BRICS_in_the_developing_world.pdf.